PNC Financial Services Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.5K | Buy |
4,294
+3,402
| +381% | +$12.2K | ﹤0.01% | 3687 |
|
|
2025
Q1 | $2.67K | Buy |
892
+843
| +1,720% | +$2.52K | ﹤0.01% | 4266 |
|
|
2024
Q4 | $164 | Sell |
49
-1,467
| -97% | -$4.91K | ﹤0.01% | 4666 |
|
|
2024
Q3 | $5.08K | Buy |
1,516
+1,260
| +492% | +$4.22K | ﹤0.01% | 4034 |
|
|
2024
Q2 | $847 | Buy |
256
+157
| +159% | +$519 | ﹤0.01% | 4460 |
|
|
2024
Q1 | $400 | Buy |
99
+25
| +34% | +$101 | ﹤0.01% | 4523 |
|
|
2023
Q4 | $226 | Buy |
+74
| New | +$226 | ﹤0.01% | 4478 |
|
|
2022
Q4 | – | Sell |
-5,000
| Closed | -$28K | – | 4763 |
|
|
2022
Q3 | $28K | Hold |
5,000
| – | – | ﹤0.01% | 3275 |
|
|
2022
Q2 | $36K | Hold |
5,000
| – | – | ﹤0.01% | 3176 |
|
|
2022
Q1 | $36K | Sell |
5,000
-132,050
| -96% | -$951K | ﹤0.01% | 3278 |
|
|
2021
Q4 | $1.23M | Buy |
137,050
+132,050
| +2,641% | +$1.18M | ﹤0.01% | 1173 |
|
|
2021
Q3 | $175K | Hold |
5,000
| – | – | ﹤0.01% | 2280 |
|
|
2021
Q2 | $107K | Hold |
5,000
| – | – | ﹤0.01% | 2614 |
|
|
2021
Q1 | $309K | Hold |
5,000
| – | – | ﹤0.01% | 1888 |
|
|
2020
Q4 | $209K | Buy |
+5,000
| New | +$209K | ﹤0.01% | 2044 |
|